6505--Rituximab Biosimilars (VA-20-00048624) Effective 9/15/2020-09/14/2021
Award Notice Posted
- Solicitation number
- 36E79720R0045
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Pfizer Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79720D0052 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Veterans Affairs awards a contract to Pfizer Inc. for the provision of Rituximab biosimilars. The contract has a period of performance from September 15, 2020 through September 14, 2021, with a total award amount of $16,746,562.56 for line item number 2 to treat condition 6505. The contracting office is located in Hines, Illinois and the award was made on July 31, 2020 under solicitation 36E79720R0045 for biosimilars.
Notice text
Awarded contract 36E79720D0052 to PFIZER INC. for 16746562.56000000 on 2020-07-31.
Files
| File | Type | Posted |
|---|---|---|
| 36E79720D0052_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| 6505--Rituximab Biosimilars (VA-20-00048624) | Solicitation | |
| 6505--Rituximab Biosimilars (VA-20-00048624) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity